{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T21:27:45Z","timestamp":1762032465945,"version":"build-2065373602"},"reference-count":107,"publisher":"Wiley","issue":"8P2","license":[{"start":{"date-parts":[[2012,1,17]],"date-time":"2012-01-17T00:00:00Z","timestamp":1326758400000},"content-version":"vor","delay-in-days":3821,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["accpjournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pharmacotherapy"],"published-print":{"date-parts":[[2001,8]]},"abstract":"<jats:p>With the rising frequency of fungal infections, as well as increasing reports of resistance to antifungal agents, it is imperative that clinically applicable antifungal susceptibility testing be available. In 1997 the National Committee for Clinical Laboratory Standards published standard guidelines for antifungal susceptibility testing of <jats:italic>Candida<\/jats:italic> sp and <jats:italic>Cryptococcus neoformans<\/jats:italic> with amphotericin B, flucytosine, fluconazole, itraconazole, and ketoconazole. Although the methods are standard, they are time consuming, can be difficult to interpret, and are approved only for testing limited organisms and drugs. Modifications to the methods and alternative approaches have been proposed to make these tests more convenient and efficient, applicable to a greater number of species, and appropriate for performing in the clinical laboratory.<\/jats:p>","DOI":"10.1592\/phco.21.12.111s.34510","type":"journal-article","created":{"date-parts":[[2004,6,9]],"date-time":"2004-06-09T05:45:58Z","timestamp":1086759958000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["In Vitro Antifungal Susceptibility Testing"],"prefix":"10.1002","volume":"21","author":[{"given":"Holly L.","family":"Hoffman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael A.","family":"Pfaller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,1,17]]},"reference":[{"doi-asserted-by":"publisher","key":"e_1_2_1_2_2","DOI":"10.1093\/jac\/36.5.751"},{"doi-asserted-by":"publisher","key":"e_1_2_1_3_2","DOI":"10.1016\/0163-4453(93)92707-4"},{"doi-asserted-by":"publisher","key":"e_1_2_1_4_2","DOI":"10.1128\/CMR.6.4.367"},{"doi-asserted-by":"publisher","key":"e_1_2_1_5_2","DOI":"10.1128\/AAC.39.1.1"},{"doi-asserted-by":"publisher","key":"e_1_2_1_6_2","DOI":"10.1093\/clinids\/24.2.235"},{"doi-asserted-by":"publisher","key":"e_1_2_1_7_2","DOI":"10.1128\/JCM.34.3.489-495.1996"},{"doi-asserted-by":"publisher","key":"e_1_2_1_8_2","DOI":"10.1128\/AAC.37.12.2517"},{"volume-title":"Reference method for broth dilution antifungal susceptibility testing of yeasts: approved standard M27\u2010A","year":"1997","author":"National Committee for Clinical Laboratory Standards.","key":"e_1_2_1_9_2"},{"doi-asserted-by":"publisher","key":"e_1_2_1_10_2","DOI":"10.1128\/JCM.30.12.3138-3145.1992"},{"doi-asserted-by":"publisher","key":"e_1_2_1_11_2","DOI":"10.1007\/BF01104343"},{"key":"e_1_2_1_12_2","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1128\/jcm.32.2.506-509.1994","article-title":"Comparative evaluation of alternative methods for broth dilution susceptibility testing of fluconazole against Candida albicans","volume":"32","author":"Pfaller M.A.","year":"1994","journal-title":"J Clin Microbiol"},{"key":"e_1_2_1_13_2","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1128\/jcm.33.5.1094-1097.1995","article-title":"Comparison of visual and spectrophotometric methods of MIC end point determinations by using broth microdilution methods to test five antifungal agents, including the new triazole D0870","volume":"33","author":"Pfaller M.A.","year":"1995","journal-title":"J Clin Microbiol"},{"key":"e_1_2_1_14_2","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1128\/jcm.32.7.1650-1653.1994","article-title":"Selection of candidate quality control isolates and tentative quality control ranges for in vitro susceptibility testing of yeast isolates by National Committee for Clinical Laboratory Standards proposed standard methods","volume":"32","author":"Pfaller M.A.","year":"1994","journal-title":"J Clin Microbiol"},{"doi-asserted-by":"publisher","key":"e_1_2_1_15_2","DOI":"10.1016\/S0732-8893(98)00031-5"},{"doi-asserted-by":"publisher","key":"e_1_2_1_16_2","DOI":"10.1016\/S0732-8893(98)00120-5"},{"doi-asserted-by":"publisher","key":"e_1_2_1_17_2","DOI":"10.1128\/AAC.39.11.2520"},{"doi-asserted-by":"publisher","key":"e_1_2_1_18_2","DOI":"10.1111\/j.1439-0507.1997.tb00234.x"},{"doi-asserted-by":"publisher","key":"e_1_2_1_19_2","DOI":"10.1016\/0732-8893(94)90034-5"},{"key":"e_1_2_1_20_2","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1128\/jcm.33.12.3154-3158.1995","article-title":"Comparison of two alternative microdilution procedures with the National Committee for Clinical Laboratory Standards reference macrodilution method M27\u2010P for in vitro testing of fluconazole\u2010resistant and \u2010susceptible isolates of Candida albicans","volume":"33","author":"Espinel\u2010Ingroff A.","year":"1995","journal-title":"J Clin Microbiol"},{"key":"e_1_2_1_21_2","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1128\/jcm.34.4.848-852.1996","article-title":"Interlaboratory evaluation of E\u2010test method for testing antifungal susceptibilities of pathogenic yeasts to five antifungal agents by using Casitone agar and solidified RPMI 1640 medium with 2% glucose","volume":"34","author":"Espinel\u2010Ingroff A.","year":"1996","journal-title":"J Clin Microbiol"},{"doi-asserted-by":"publisher","key":"e_1_2_1_22_2","DOI":"10.1128\/JCM.29.6.1089-1094.1991"},{"doi-asserted-by":"publisher","key":"e_1_2_1_23_2","DOI":"10.1128\/AAC.37.1.39"},{"doi-asserted-by":"publisher","key":"e_1_2_1_24_2","DOI":"10.1016\/0732-8893(94)90044-2"},{"doi-asserted-by":"publisher","key":"e_1_2_1_25_2","DOI":"10.1016\/0732-8893(94)90096-5"},{"key":"e_1_2_1_26_2","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1128\/JCM.37.3.591-595.1999","article-title":"Multicenter comparison of the sensititre YeastOne colorimetric antifungal panel with the National Committee for Clinical Laboratory Standards M27\u2010A reference method for testing clinical isolates of common and emerging Candida spp., Cryptococcus spp., and other yeasts and yeast\u2010like organisms","volume":"37","author":"Espinel\u2010Ingroff A.","year":"1999","journal-title":"J Clin Microbiol"},{"doi-asserted-by":"publisher","key":"e_1_2_1_27_2","DOI":"10.1128\/JCM.32.8.1992-1996.1994"},{"key":"e_1_2_1_28_2","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1128\/jcm.32.7.1625-1628.1994","article-title":"Multisite reproducibility of colorimetric broth microdilution method for antifungal susceptibility testing of yeast isolates","volume":"32","author":"Pfaller M.A.","year":"1994","journal-title":"J Clin Microbiol"},{"doi-asserted-by":"publisher","key":"e_1_2_1_29_2","DOI":"10.1016\/S0732-8893(98)00026-1"},{"doi-asserted-by":"publisher","key":"e_1_2_1_30_2","DOI":"10.1093\/jac\/42.4.439"},{"doi-asserted-by":"publisher","key":"e_1_2_1_31_2","DOI":"10.1016\/S0732-8893(00)00174-7"},{"key":"e_1_2_1_32_2","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1128\/jcm.33.4.915-917.1995","article-title":"Use of a colorimetric system for yeast susceptibility testing","volume":"33","author":"Tiballi R.N.","year":"1995","journal-title":"J Clin Microbiol"},{"doi-asserted-by":"publisher","key":"e_1_2_1_33_2","DOI":"10.1128\/JCM.33.10.2660-2664.1995"},{"doi-asserted-by":"publisher","key":"e_1_2_1_34_2","DOI":"10.1111\/j.1439-0507.1998.tb00709.x"},{"key":"e_1_2_1_35_2","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1128\/JCM.38.8.2949-2954.2000","article-title":"Comparison of NCCLS and 3\u2010(4,5\u2010dimethyl\u20102\u2010thiazyl)\u20102, 5\u2010diphenyl\u20102H\u2010 tetrazolium bromide (MTT) methods of in vitro susceptibility testing of filamentous fungi and development of a new simplified method","volume":"38","author":"Meletiadis J.","year":"2000","journal-title":"J Clin Microbiol"},{"key":"e_1_2_1_36_2","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1128\/JCM.38.1.333-340.2000","article-title":"Determination of antifungal MICs by a rapid susceptibility assay","volume":"38","author":"Riesselman M.H.","year":"2000","journal-title":"J Clin Microbiol"},{"key":"e_1_2_1_37_2","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1128\/JCM.38.6.2334-2338.2000","article-title":"Comparison of a new colorimetric assay with the NCCLS broth microdilution method (M\u201027A) for antifungal drug MIC determination","volume":"38","author":"Li R.K.","year":"2000","journal-title":"J Clin Microbiol"},{"doi-asserted-by":"publisher","key":"e_1_2_1_38_2","DOI":"10.1128\/AAC.35.8.1641"},{"doi-asserted-by":"publisher","key":"e_1_2_1_39_2","DOI":"10.1128\/AAC.38.6.1422"},{"doi-asserted-by":"publisher","key":"e_1_2_1_40_2","DOI":"10.1128\/jcm.26.8.1437-1441.1988"},{"doi-asserted-by":"publisher","key":"e_1_2_1_41_2","DOI":"10.1128\/AAC.40.10.2387"},{"key":"e_1_2_1_42_2","doi-asserted-by":"crossref","first-page":"3715","DOI":"10.1128\/JCM.38.10.3715-3717.2000","article-title":"Evaluation of the E\u2010test method for determining voriconazole susceptibilities of 312 clinical isolates of Candida species by using three different agar media","volume":"38","author":"Pfaller M.A.","year":"2000","journal-title":"J Clin Microbiol"},{"key":"e_1_2_1_43_2","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1128\/jcm.34.7.1691-1693.1996","article-title":"Multisite reproducibility of the E\u2010test MIC method for antifungal susceptibility testing of yeast isolates","volume":"34","author":"Pfaller M.A.","year":"1996","journal-title":"J Clin Microbiol"},{"doi-asserted-by":"publisher","key":"e_1_2_1_44_2","DOI":"10.1046\/j.1439-0507.2000.00574.x"},{"doi-asserted-by":"publisher","key":"e_1_2_1_45_2","DOI":"10.1093\/jac\/46.5.815"},{"key":"e_1_2_1_46_2","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1128\/jcm.32.9.2099-2102.1994","article-title":"Comparison of broth macrodilution, broth microdilution, and E\u2010test antifungal susceptibility tests for fluconazole","volume":"32","author":"Sewell D.L.","year":"1994","journal-title":"J Clin Microbiol"},{"doi-asserted-by":"publisher","key":"e_1_2_1_47_2","DOI":"10.1128\/JCM.37.5.1480-1483.1999"},{"key":"e_1_2_1_48_2","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1128\/jcm.34.4.842-847.1996","article-title":"Fluconazole and amphotericin B antifungal susceptibility testing by National Committee for Clinical Laboratory Standards broth macrodilution method compared with E\u2010test and semiautomated broth microdilution test","volume":"34","author":"Eldere J.","year":"1996","journal-title":"J Clin Microbiol"},{"doi-asserted-by":"publisher","key":"e_1_2_1_49_2","DOI":"10.1128\/AAC.36.9.1805"},{"key":"e_1_2_1_50_2","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1128\/jcm.34.9.2154-2157.1996","article-title":"Fluconazole disk diffusion procedure for determining susceptibility of Candida species","volume":"34","author":"Barry A.L.","year":"1996","journal-title":"J Clin Microbiol"},{"doi-asserted-by":"publisher","key":"e_1_2_1_51_2","DOI":"10.1007\/BF01992164"},{"doi-asserted-by":"publisher","key":"e_1_2_1_52_2","DOI":"10.1023\/A:1007068826861"},{"doi-asserted-by":"publisher","key":"e_1_2_1_53_2","DOI":"10.1016\/S0732-8893(99)00152-2"},{"key":"e_1_2_1_54_2","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1128\/JCM.36.5.1330-1332.1998","article-title":"Comparative evaluation of National Committee for Clinical Laboratory Standards broth macrodilution and agar dilution screening methods for testing fluconazole susceptibility of Cryptococcus neoformans","volume":"36","author":"Kirkpatrick W.R.","year":"1998","journal-title":"J Clin Microbiol"},{"doi-asserted-by":"publisher","key":"e_1_2_1_55_2","DOI":"10.1128\/jcm.35.1.5-10.1997"},{"key":"e_1_2_1_56_2","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1128\/jcm.35.9.2320-2324.1997","article-title":"Rapid flow cytometric susceptibility testing of Candida albicans","volume":"35","author":"Ramani R.","year":"1997","journal-title":"J Clin Microbiol"},{"doi-asserted-by":"publisher","key":"e_1_2_1_57_2","DOI":"10.1128\/AAC.44.10.2752-2758.2000"},{"doi-asserted-by":"publisher","key":"e_1_2_1_58_2","DOI":"10.1093\/jac\/43.2.227"},{"doi-asserted-by":"publisher","key":"e_1_2_1_59_2","DOI":"10.1086\/513663"},{"doi-asserted-by":"publisher","key":"e_1_2_1_60_2","DOI":"10.1128\/CMR.9.4.499"},{"doi-asserted-by":"publisher","key":"e_1_2_1_61_2","DOI":"10.1016\/S0002-9343(95)00010-0"},{"doi-asserted-by":"publisher","key":"e_1_2_1_62_2","DOI":"10.1016\/S0732-8893(98)00160-6"},{"doi-asserted-by":"publisher","key":"e_1_2_1_63_2","DOI":"10.1016\/S0732-8893(99)00046-2"},{"doi-asserted-by":"publisher","key":"e_1_2_1_64_2","DOI":"10.1016\/S0732-8893(97)00192-2"},{"doi-asserted-by":"publisher","key":"e_1_2_1_65_2","DOI":"10.1016\/S0732-8893(97)00240-X"},{"doi-asserted-by":"publisher","key":"e_1_2_1_66_2","DOI":"10.1128\/JCM.36.6.1518-1529.1998"},{"doi-asserted-by":"publisher","key":"e_1_2_1_67_2","DOI":"10.1128\/JCM.36.7.1886-1889.1998"},{"doi-asserted-by":"publisher","key":"e_1_2_1_68_2","DOI":"10.1093\/clinids\/17.Supplement_2.S494"},{"doi-asserted-by":"publisher","key":"e_1_2_1_69_2","DOI":"10.1128\/AAC.42.1.129"},{"key":"e_1_2_1_70_2","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1128\/jcm.35.6.1473-1476.1997","article-title":"Effects of incubation time and buffer concentration on in vitro activities of antifungal agents against Candida albicans","volume":"35","author":"Tornatore M.A.","year":"1997","journal-title":"J Clin Microbiol"},{"key":"e_1_2_1_71_2","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1128\/JCM.36.1.153-156.1998","article-title":"Interpretation of trailing end points in antifungal susceptibility testing by the National Committee for Clinical Laboratory Standards method","volume":"36","author":"Revankar S.G.","year":"1998","journal-title":"J Clin Microbiol"},{"key":"e_1_2_1_72_2","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1128\/AAC.43.6.1383","article-title":"The trailing end point phenotype in antifungal susceptibility testing is pH dependent","volume":"43","author":"Marr K.A.","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"doi-asserted-by":"publisher","key":"e_1_2_1_73_2","DOI":"10.1111\/j.1439-0507.1993.tb00699.x"},{"key":"e_1_2_1_74_2","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1128\/jcm.33.7.1884-1889.1995","article-title":"Initial use of a broth microdilution method suitable for in vitro testing of fungal isolates in a clinical microbiology laboratory","volume":"33","author":"Hacek D.M.","year":"1995","journal-title":"J Clin Microbiol"},{"key":"e_1_2_1_75_2","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1128\/AAC.40.9.1998","article-title":"Comparison of a spectrophotometric microdilution method with RPMI\u20102% glucose with the National Committee for Clinical Laboratory Standards reference macrodilution method M27\u2010P for in vitro susceptibility testing of amphotericin B, flucytosine, and fluconazole against Candida albicans","volume":"40","author":"Rodriguez\u2010Tudela J.L.","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"doi-asserted-by":"publisher","key":"e_1_2_1_76_2","DOI":"10.1128\/jcm.30.11.2881-2886.1992"},{"doi-asserted-by":"publisher","key":"e_1_2_1_77_2","DOI":"10.1128\/AAC.44.6.1544-1548.2000"},{"doi-asserted-by":"publisher","key":"e_1_2_1_78_2","DOI":"10.1093\/clinids\/22.2.322"},{"doi-asserted-by":"publisher","key":"e_1_2_1_79_2","DOI":"10.1128\/JCM.34.5.1280-1282.1996"},{"doi-asserted-by":"publisher","key":"e_1_2_1_80_2","DOI":"10.1016\/0002-9343(94)90088-4"},{"key":"e_1_2_1_81_2","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1128\/jcm.29.2.393-394.1991","article-title":"Spectrophotometric method of inoculum preparation for the in vitro susceptibility testing of filamentous fungi","volume":"29","author":"Espinel\u2010Ingroff A.","year":"1991","journal-title":"J Clin Microbiol"},{"doi-asserted-by":"publisher","key":"e_1_2_1_82_2","DOI":"10.1128\/AAC.39.2.314"},{"key":"e_1_2_1_83_2","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1128\/jcm.33.5.1302-1307.1995","article-title":"Effect of increasing inoculum sizes of pathogenic filamentous fungi on MICs of antifungal agents by broth microdilution method","volume":"33","author":"Gehrt A.","year":"1995","journal-title":"J Clin Microbiol"},{"doi-asserted-by":"publisher","key":"e_1_2_1_84_2","DOI":"10.1128\/jcm.35.1.139-143.1997"},{"volume-title":"Reference method for broth dilution antifungal susceptibility testing of conidium\u2010forming filamentous fungi; proposed standard M38\u2010P","year":"1998","author":"National Committee for Clinical Laboratory Standards.","key":"e_1_2_1_85_2"},{"doi-asserted-by":"publisher","key":"e_1_2_1_86_2","DOI":"10.1128\/AAC.44.2.239-242.2000"},{"doi-asserted-by":"publisher","key":"e_1_2_1_87_2","DOI":"10.1139\/w99-075"},{"doi-asserted-by":"publisher","key":"e_1_2_1_88_2","DOI":"10.1128\/JCM.38.9.3359-3361.2000"},{"doi-asserted-by":"publisher","key":"e_1_2_1_89_2","DOI":"10.1128\/jcm.35.1.270-272.1997"},{"doi-asserted-by":"publisher","key":"e_1_2_1_90_2","DOI":"10.1128\/AAC.39.4.906"},{"doi-asserted-by":"publisher","key":"e_1_2_1_91_2","DOI":"10.1128\/AAC.44.3.747-751.2000"},{"doi-asserted-by":"publisher","key":"e_1_2_1_92_2","DOI":"10.1016\/S0732-8893(97)00245-9"},{"doi-asserted-by":"publisher","key":"e_1_2_1_93_2","DOI":"10.1128\/AAC.39.1.40"},{"key":"e_1_2_1_94_2","first-page":"800","article-title":"The prevalence of oral thrush and fluconazole resistant thrush in HIV+ patients [abstr]","volume":"21","author":"Webb M.L.","year":"1995","journal-title":"Clin Infect Dis"},{"key":"e_1_2_1_95_2","first-page":"708","article-title":"Evaluation of fluconazole in the treatment of oropharyngeal candidiasis in patients with AIDS","volume":"13","author":"Quart A.M.","year":"1996","journal-title":"Infect Med"},{"doi-asserted-by":"publisher","key":"e_1_2_1_96_2","DOI":"10.1128\/jcm.34.7.1794-1797.1996"},{"doi-asserted-by":"publisher","key":"e_1_2_1_97_2","DOI":"10.1080\/02681219680000171"},{"doi-asserted-by":"publisher","key":"e_1_2_1_98_2","DOI":"10.1016\/0002-9343(94)90300-X"},{"doi-asserted-by":"publisher","key":"e_1_2_1_99_2","DOI":"10.1093\/clinids\/18.2.240"},{"doi-asserted-by":"publisher","key":"e_1_2_1_100_2","DOI":"10.1056\/NEJM199411173312001"},{"doi-asserted-by":"publisher","key":"e_1_2_1_101_2","DOI":"10.1086\/513927"},{"doi-asserted-by":"publisher","key":"e_1_2_1_102_2","DOI":"10.1001\/archinte.1995.00430220087009"},{"doi-asserted-by":"publisher","key":"e_1_2_1_103_2","DOI":"10.1086\/514193"},{"doi-asserted-by":"publisher","key":"e_1_2_1_104_2","DOI":"10.7326\/0003-4819-104-2-234"},{"doi-asserted-by":"publisher","key":"e_1_2_1_105_2","DOI":"10.1056\/NEJM198708063170602"},{"doi-asserted-by":"publisher","key":"e_1_2_1_106_2","DOI":"10.1128\/AAC.42.2.282"},{"doi-asserted-by":"publisher","key":"e_1_2_1_107_2","DOI":"10.1093\/jac\/42.4.497"},{"doi-asserted-by":"publisher","key":"e_1_2_1_108_2","DOI":"10.1093\/clinids\/24.5.776"}],"container-title":["Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1592%2Fphco.21.12.111S.34510","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1592\/phco.21.12.111S.34510","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:13:35Z","timestamp":1761041615000},"score":1,"resource":{"primary":{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/10.1592\/phco.21.12.111S.34510"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,8]]},"references-count":107,"journal-issue":{"issue":"8P2","published-print":{"date-parts":[[2001,8]]}},"alternative-id":["10.1592\/phco.21.12.111S.34510"],"URL":"https:\/\/doi.org\/10.1592\/phco.21.12.111s.34510","archive":["Portico"],"relation":{},"ISSN":["0277-0008","1875-9114"],"issn-type":[{"type":"print","value":"0277-0008"},{"type":"electronic","value":"1875-9114"}],"subject":[],"published":{"date-parts":[[2001,8]]},"assertion":[{"value":"2012-01-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}